Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-22-032972
Filing Date
2022-09-12
Accepted
2022-09-09 21:50:15
Documents
1
Group Members
DAVID C. OTTDRAGSA 96 LLCO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTERVIKING GLOBAL OPPORTUNITIES PARENT GP LLCVIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10041775_sc13ga.htm SC 13G/A 299211
  Complete submission text file 0001140361-22-032972.txt   301021
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

EIN.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Subject) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93265 | Film No.: 221237261
SIC: 2834 Pharmaceutical Preparations